Covid-19 Antibodies
- All
- News
- Videos
- Photos
-
Antibody That Can Counter All Known Covid Variants Found
- Monday September 9, 2024
- World News | Press Trust of India
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
- www.ndtv.com
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
- Friday September 16, 2022
- India News | Press Trust of India
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
- www.ndtv.com
-
Nearly 60% Of US Population Had Covid By February: Health Body
- Wednesday April 27, 2022
- World News | Agence France-Presse
By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.
- www.ndtv.com
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
- Wednesday February 16, 2022
- World News | Press Trust of India
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
- www.ndtv.com
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
- Tuesday February 15, 2022
- India News | Press Trust of India
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
- www.ndtv.com
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
- Sunday February 6, 2022
- World News | Asian News International
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
- www.ndtv.com
-
Omicron Generated Antibodies Effective Against All Variants Of Concern: Top Medical Body Study
- Wednesday January 26, 2022
- India News | Asian News International
The latest study conducted by Indian Council of Medical Research (ICMR) shows that antibodies generated by Omicron, a COVID-19 strain, are not only effective against it but also other variants of concern (VOCs) including Delta.
- www.ndtv.com
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
- Monday January 24, 2022
- World News | Press Trust of India
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
- www.ndtv.com
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
- Monday January 24, 2022
- India News | Asian News International
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
- www.ndtv.com
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
- Thursday January 20, 2022
- Science | Press Trust of India
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
- www.ndtv.com
-
Booster Dose Neutralises Omicron Variant, Finds Study
- Sunday January 16, 2022
- World News | Asian News International
An international team of researchers recently studied the sensitivity of Omicron to antibodies compared with the currently dominant Delta variant. The study about this variant has been published in the 'Nature Journal'.
- www.ndtv.com
-
2 New Medicines For Covid Treatment Get WHO Approval
- Friday January 14, 2022
- World News | Marthe Fourcade, Bloomberg
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
- www.ndtv.com
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
- Thursday January 13, 2022
- World News | Reuters
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
- www.ndtv.com
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
- Thursday December 23, 2021
- World News | Reuters
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
- www.ndtv.com
-
Antibody That Can Counter All Known Covid Variants Found
- Monday September 9, 2024
- World News | Press Trust of India
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
- www.ndtv.com
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
- Friday September 16, 2022
- India News | Press Trust of India
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
- www.ndtv.com
-
Nearly 60% Of US Population Had Covid By February: Health Body
- Wednesday April 27, 2022
- World News | Agence France-Presse
By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.
- www.ndtv.com
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
- Wednesday February 16, 2022
- World News | Press Trust of India
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
- www.ndtv.com
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
- Tuesday February 15, 2022
- India News | Press Trust of India
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
- www.ndtv.com
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
- Sunday February 6, 2022
- World News | Asian News International
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
- www.ndtv.com
-
Omicron Generated Antibodies Effective Against All Variants Of Concern: Top Medical Body Study
- Wednesday January 26, 2022
- India News | Asian News International
The latest study conducted by Indian Council of Medical Research (ICMR) shows that antibodies generated by Omicron, a COVID-19 strain, are not only effective against it but also other variants of concern (VOCs) including Delta.
- www.ndtv.com
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
- Monday January 24, 2022
- World News | Press Trust of India
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
- www.ndtv.com
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
- Monday January 24, 2022
- India News | Asian News International
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
- www.ndtv.com
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
- Thursday January 20, 2022
- Science | Press Trust of India
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
- www.ndtv.com
-
Booster Dose Neutralises Omicron Variant, Finds Study
- Sunday January 16, 2022
- World News | Asian News International
An international team of researchers recently studied the sensitivity of Omicron to antibodies compared with the currently dominant Delta variant. The study about this variant has been published in the 'Nature Journal'.
- www.ndtv.com
-
2 New Medicines For Covid Treatment Get WHO Approval
- Friday January 14, 2022
- World News | Marthe Fourcade, Bloomberg
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
- www.ndtv.com
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
- Thursday January 13, 2022
- World News | Reuters
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
- www.ndtv.com
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
- Thursday December 23, 2021
- World News | Reuters
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
- www.ndtv.com